From Patent to PMA
July 1, 2001
Originally Published MX July/August 2001
Cover Story
Percardia CEO Nancy Briefs says her company has the technology, talent, and tenacity necessary to be a leader in the cardiovascular marketplace.
Interview by Stacey L. Bell
Since its inception a mere three years ago, Percardia (Merrimack, NH) has raised a total of $32 million in funding—and the company is just getting started. Under the leadership of CEO Nancy Briefs, Percardia has built a solid patent portfolio, recruited an expert scientific advisory board and a top-notch management team, demonstrated proof of concept for its new technology, and reached several key milestones. These accomplishments have not gone unnoticed; Percardia counts among its key investors cardiac giant Medtronic (Minneapolis).
Not a bad beginning for a start-up. In fact, the story of Percardia's development is just as compelling to investors as its core technology. The company was founded by a
About the Author(s)
You May Also Like